You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
5 March 2018
ViraTherapeutics starts second oncolytic virus development program with Boehringer Ingelheim
30 May 2017
ViraTherapeutics appoints Heinz Schwer as CEO
28 September 2016
ViraTherapeutics GmbH: Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with ViraTherapeutics